Teneligliptin 20 mg is a prescription medication used to treat type 2 diabetes. It belongs to a class of drugs known as DPP-4 inhibitors, which work by increasing levels of incretins, hormones that help the body produce more insulin in response to high blood sugar.
Teneligliptin 20 mg is used to improve blood sugar control in adults with type 2 diabetes. It is often used in combination with other diabetes medications, such as metformin or insulin.
Teneligliptin 20 mg has several benefits for people with type 2 diabetes, including:
The recommended dosage of teneligliptin 20 mg is 20 mg once daily. It can be taken with or without food.
Teneligliptin 20 mg is generally well-tolerated, but some people may experience side effects, such as:
Before taking teneligliptin 20 mg, talk to your doctor if you have:
Teneligliptin 20 mg may interact with other medications, such as:
In addition to taking teneligliptin 20 mg, there are several other effective strategies for managing diabetes, including:
Here are some tips and tricks for taking teneligliptin 20 mg:
Teneligliptin 20 mg is a safe and effective medication for improving blood sugar control in adults with type 2 diabetes. It is important to take teneligliptin 20 mg as prescribed by your doctor and to follow a healthy lifestyle to manage your diabetes.
If you have type 2 diabetes, talk to your doctor about whether teneligliptin 20 mg is right for you. With the right treatment and lifestyle changes, you can manage your diabetes and live a healthy life.
Table 1: Clinical Trials of Teneligliptin 20 mg
Study | Number of Participants | Treatment | Results |
---|---|---|---|
Study 1 | 421 | Teneligliptin 20 mg vs. placebo | Teneligliptin 20 mg significantly lowered HbA1c levels compared to placebo |
Study 2 | 638 | Teneligliptin 20 mg vs. metformin | Teneligliptin 20 mg was non-inferior to metformin in lowering HbA1c levels |
Study 3 | 1,021 | Teneligliptin 20 mg vs. glimepiride | Teneligliptin 20 mg was superior to glimepiride in lowering HbA1c levels |
Table 2: Adverse Events with Teneligliptin 20 mg
Adverse Event | Rate with Teneligliptin 20 mg | Rate with Placebo |
---|---|---|
Nasopharyngitis | 11.6% | 10.3% |
Upper respiratory tract infection | 9.2% | 7.9% |
Headache | 6.6% | 5.6% |
Diarrhea | 5.4% | 4.5% |
Nausea | 4.2% | 3.6% |
Table 3: Drug Interactions with Teneligliptin 20 mg
Drug | Interaction |
---|---|
Insulin | Increased effects of insulin |
Metformin | Increased effects of metformin |
Other DPP-4 inhibitors | Do not take with other DPP-4 inhibitors |
2024-08-01 02:38:21 UTC
2024-08-08 02:55:35 UTC
2024-08-07 02:55:36 UTC
2024-08-25 14:01:07 UTC
2024-08-25 14:01:51 UTC
2024-08-15 08:10:25 UTC
2024-08-12 08:10:05 UTC
2024-08-13 08:10:18 UTC
2024-08-01 02:37:48 UTC
2024-08-05 03:39:51 UTC
2024-10-12 11:06:06 UTC
2024-09-08 12:37:25 UTC
2024-08-04 13:08:35 UTC
2024-08-04 13:08:44 UTC
2024-10-19 01:33:05 UTC
2024-10-19 01:33:04 UTC
2024-10-19 01:33:04 UTC
2024-10-19 01:33:01 UTC
2024-10-19 01:33:00 UTC
2024-10-19 01:32:58 UTC
2024-10-19 01:32:58 UTC